Loading…
Vivanza Biosciences (BSE 530057)₹1.45−2.03%Pharmaceuticals
At the end of the Mar 2026 quarter, Vivanza Biosciences' shareholders were: promoters 20.08%, public 79.92%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 19,451 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 47.86% | 47.35% | 44.96% | 43.30% | 40.11% | 39.92% | 20.08% | 20.08% | 20.08% | 20.08% | 20.08% | 20.08% |
| Public | 52.14% | 52.65% | 55.04% | 56.70% | 59.89% | 60.08% | 79.92% | 79.92% | 79.92% | 79.92% | 79.92% | 79.92% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 4,865 | 5,037 | 5,934 | 6,989 | 16,933 | 16,693 | 20,625 | 20,823 | 20,448 | 20,160 | 19,812 | 19,451 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Parth Hemant Parikh | Promoter | 19.71% | 0.00 |
| Ashoka Metcast Limited | Public | 3.83% | 0.00 |
| Ravinder Singh | Public | 1.51% | +0.47 |
| Prashant Tyagi | Public | 1.50% | 0.00 |
| Manu Narang | Public | 1.32% | +0.06 |
| Hemant Amrish Parikh | Promoter | 0.25% | 0.00 |
Promoters held 20.08% of Vivanza Biosciences at the end of the Mar 2026 quarter, the same as a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Vivanza Biosciences had 19,451 shareholders at the end of the Mar 2026 quarter, against 20,823 a year earlier.
Ashoka Metcast Limited (Public) held 3.83% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.